DR. ANDREW MEDVEDOVSKY MD NPI 1649431594

NPI Details

DR. Andrew Medvedovsky, MD is a pain medicine pain medicine in Jacksonville, FL with 19 years of experience. The provider is pain Medicine is a primary medical specialty based on a distinct body of knowledge and a well-defined scope of clinical practice that is founded on science, research and education. It is concerned with the study of pain, the prevention of pain, and the evaluation, treatment, and rehabilitation of persons in pain. A comprehensive evaluation incorporates the physical, psychological, cognitive and socio-cultural contributions to pain. The treatment protocol may include pharmacological, invasive, behavioral, cognitive, rehabilitative and complementary strategies provided in a concurrent focused and patient specific manner. The pain medicine physician often serves the patient as a frontline physician regarding their pain, but also may serve as a consultant to other physicians, direct an interdisciplinary/multidisciplinary treatment team, conduct research, or advocate for the patient's pain care with public and private agencies. The Pain Medicine physician may work in variety of settings including office, clinic, hospital, university, or governmental/public agencies. DR. Andrew Medvedovsky, MD NPI is 1649431594. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

2700 RIVERSIDE AVE SUITE 2
JACKSONVILLE, FL
ZIP 32205-194
Phone: (904) 265-7020
Fax: (833) 578-1806

The NPI 1649431594 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance (HCPCS:27096)
• Injection of lower or sacral spine facet joint using imaging guidance, single level (HCPCS:64493)
• Injection of lower or sacral spine facet joint using imaging guidance, second level (HCPCS:64494)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Injection of upper or middle spine facet joint using imaging guidance, single level (HCPCS:64490)
• Injection of upper or middle spine facet joint using imaging guidance, second level (HCPCS:64491)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin (HCPCS:0275T)
• Injection of anesthetic agent and/or steroid into upper neck and back of head nerve (HCPCS:64405)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64634)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64633)
• Spinal fusion (HCPCS:NAN02)

The enumeration date for this NPI number is 6/23/2008 and was last updated on 9/18/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: